Search research articles
Contact Us
Filters
Showing results (41-50 of 62) with videos related to
Page
of 7
Sort By:
Circulation. Cardiovascular Interventions
|
October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study
Giora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions
|
December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents
Akiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions
|
March 9, 2016
Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study"
Giora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
The American Journal of Cardiology
|
September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)
Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
JACC. Cardiovascular Interventions
|
January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)
Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Thomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology
|
December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions
|
February 15, 2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)
Jennifer Yu, Roxana Mehran, Usman Baber, et al.
The American Journal of Cardiology
|
April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Gennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
American Heart Journal
|
March 22, 2019
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Matthew T Finn, Björn Redfors, Dimitri Karmpaliotis, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 62) with videos related to
Sort By:
Page
of 7
Circulation. Cardiovascular Interventions
|
October 14, 2015
Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study
Giora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
Circulation. Cardiovascular Interventions
|
December 21, 2018
Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents
Akiko Maehara, Gary S Mintz, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions
|
March 9, 2016
Response to Letter Regarding Article, "Proton Pump Inhibitors, Platelet Reactivity, and Cardiovascular Outcomes After Drug-Eluting Stents in Clopidogrel-Treated Patients: The ADAPT-DES Study"
Giora Weisz, Nathaniel R Smilowitz, Ajay J Kirtane, et al.
The American Journal of Cardiology
|
September 4, 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study)
Björn Redfors, Shmuel Chen, Ori Ben-Yehuda, et al.
JACC. Cardiovascular Interventions
|
January 8, 2016
Is There an Ideal Level of Platelet P2Y12-Receptor Inhibition in Patients Undergoing Percutaneous Coronary Intervention?: "Window" Analysis From the ADAPT-DES Study (Assessment of Dual AntiPlatelet Therapy With Drug-Eluting Stents)
Ajay J Kirtane, Puja B Parikh, Thomas D Stuckey, et al.
JACC. Cardiovascular Interventions
|
August 7, 2017
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study
Thomas D Stuckey, Ajay J Kirtane, Bruce R Brodie, et al.
The American Journal of Cardiology
|
December 8, 2015
Impact of Hemoglobin A1c Levels on Residual Platelet Reactivity and Outcomes After Insertion of Coronary Drug-Eluting Stents (from the ADAPT-DES Study)
Mikkel M Schoos, George D Dangas, Roxana Mehran, et al.
Circulation. Cardiovascular Interventions
|
February 15, 2017
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents)
Jennifer Yu, Roxana Mehran, Usman Baber, et al.
The American Journal of Cardiology
|
April 13, 2016
Relation Between Platelet Count and Platelet Reactivity to Thrombotic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study
Gennaro Giustino, Ajay J Kirtane, Philippe Généreux, et al.
American Heart Journal
|
March 22, 2019
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study
Matthew T Finn, Björn Redfors, Dimitri Karmpaliotis, et al.
Page
of 7